LANGSTEIN HOWARD N. enters TELA BIO, INC. with 71.35K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/11/2026ACC: 0002117151-26-000002
Officer· Chief Medical Officer
Since Mar 2026
71.35K
Baseline shares
100% direct
71.35K
Direct ownership
1 position
72.75K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned71.35K
Total
71.35K direct71.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 71.35K | Direct |
| Total | 71.35K | 71.35K direct |
Derivative Holdings1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
72.75K
Shares owned
N/A
Exercise price
0.783
Expiration
—
Exercise window
—
Total
Underlying
72.75K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 0.783 | — | — | 72.75K | N/A |
| Total | 72.75K | 0.00 | ||||